Next-gen flu vaccines use proteolysis-targeting to boost safety and cross-strain immunity in animal models

Recently, Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a library of live-attenuated influenza A vaccines that utilize diverse E3 ubiquitin ligases to degrade viral proteins and achieve virus attenuation, and developed the next-generation proteolysis-targeting (PROTAR) strategy, PROTAR 2.0.
👉 Full Story

Psycho Runs Over Cop during DUI Traffic Stop
- Our favorite budget earbuds are back on sale for $45 - Lawrence Bonk
- ‘Sitar For Mental Health’ (Delhi) Review | Rishab Rikhiram Sharma’s Soul-Stirring Sitar Concert That Transcended Time - Aayush Sharma
- Your Favorite Sci-Fi TV Show Will Never Be As Successful As NCIS - Jonathan Klotz
- How To Become A Grant Writer With No Experience - Aamir Zahoor
- Speedrunner reaches Breath of the Wild credits on Switch 2, a console which isn't even out yet - Matt Tate
- Recall Roundup: Apple Juice, Coffee Creamer, and More Pulled From Shelves This Week - Jenna Anderson

We Tried India's Biggest Battery Phone!
- Work Life Balance: Importance, Tips And Ideas To Improve - Aamir Zahoor
- Bring It On’s Big Cash Bingo surpasses $500K in monthly revenues and 80,000 players - Dean Takahashi
- Can the Abundance Agenda Ever Really Succeed on the Left?
- Beyond A2A and MCP: How LOKA’s Universal Agent Identity Layer changes the game - Emilia David
- Researchers call for better support for families of children who die suddenly
- Bowen Yang, Wanda Sykes, Niecy Nash-Betts Among Honorees For Critics Choice Celebration Of LGBTQ+ Cinema & Television - Pete Hammond